TurtleTree, founded in 2019, is at the forefront of a health and sustainability revolution, operating at the intersection of Biotechnology and Food and Beverage industries. Headquartered in the United States, the company has developed LF+, the world’s first vegan lactoferrin, through advanced precision fermentation technology.
LF+ marks a significant innovation in bioactive milk protein, enhancing nutritional value across a variety of applications from plant-based foods to skincare products. This breakthrough not only boosts human health but upholds ethical standards, promoting animal welfare.
After raising a substantial $32.90M Series A on 01 November 2021 with contributions from investors like Verso Capital and Artesian Capital Management, TurtleTree is actively seeking further partnerships and investments. The startup encapsulates the essence of its slogan, "We created LF+, the world’s first vegan lactoferrin. Partner, invest, and join the health revolution."